The Global Lysosomal Storage Diseases Therapeutics Market estimated at US$7 Billion in the year 2020, is projected to reach a revised size of US$10.3 Billion by 2028, growing at a CAGR of 5% during the forecast period 2022-2028. Lysosomal storage disorders (LSDs) are a group of rare genetic metabolic disorders caused by defects in lysosomal […]
